NOVO.B.DK

277.65

+1.83%↑

GMAB.DK

1,689.5

-0.03%↓

HLUNB.DK

42.42

-0.98%↓

ZEAL.DK

309.2

+3.27%↑

AMBUB.DK

65.2

+3.33%↑

NOVO.B.DK

277.65

+1.83%↑

GMAB.DK

1,689.5

-0.03%↓

HLUNB.DK

42.42

-0.98%↓

ZEAL.DK

309.2

+3.27%↑

AMBUB.DK

65.2

+3.33%↑

NOVO.B.DK

277.65

+1.83%↑

GMAB.DK

1,689.5

-0.03%↓

HLUNB.DK

42.42

-0.98%↓

ZEAL.DK

309.2

+3.27%↑

AMBUB.DK

65.2

+3.33%↑

NOVO.B.DK

277.65

+1.83%↑

GMAB.DK

1,689.5

-0.03%↓

HLUNB.DK

42.42

-0.98%↓

ZEAL.DK

309.2

+3.27%↑

AMBUB.DK

65.2

+3.33%↑

NOVO.B.DK

277.65

+1.83%↑

GMAB.DK

1,689.5

-0.03%↓

HLUNB.DK

42.42

-0.98%↓

ZEAL.DK

309.2

+3.27%↑

AMBUB.DK

65.2

+3.33%↑

Search

Coloplast A-S (Class B)

Abrir

402 1.88

Visão Geral

Variação de preço das ações

24h

Atual

Mín

400.6

Máximo

402.1

Indicadores-chave

By Trading Economics

Rendimento

522M

1.4B

Vendas

83M

7B

P/E

Médio do Setor

22.883

67.147

EPS

6.32

Rendimento de Dividendos

5.69

Margem de lucro

19.835

Funcionários

16,983

EBITDA

309M

2.3B

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+11.86% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

5.69%

2.36%

Próximos Ganhos

12 de mai. de 2026

Próxima data de dividendos

20 de mai. de 2026

Próxima data de ex-dividendo

18 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-27B

91B

Abertura anterior

400.12

Fecho anterior

402

Coloplast A-S (Class B) Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de mai. de 2026, 23:47 UTC

Ganhos

National Australia Bank Warns of Economic Shock as 1st Half Profit Falls -- Update

3 de mai. de 2026, 22:35 UTC

Ganhos

National Australia Bank Holds Dividend Despite 19% 1st Half Profit Drop

3 de mai. de 2026, 23:39 UTC

Conversa de Mercado

Gold Edge Higher Amid Signs of Resilience -- Market Talk

3 de mai. de 2026, 23:34 UTC

Conversa de Mercado

Oil Declines Amid Mild Risk-on Sentiment -- Market Talk

3 de mai. de 2026, 23:32 UTC

Ganhos

National Australia Bank Warns of Economic Shock as 1H Profit Falls -- Update

3 de mai. de 2026, 23:30 UTC

Conversa de Mercado

Nickel Industries Result Shows Power of Higher Prices -- Market Talk

3 de mai. de 2026, 23:20 UTC

Conversa de Mercado

RBA Likely to Hike Rates; Guidance and Board Split Key -- Market Talk

3 de mai. de 2026, 23:16 UTC

Aquisições, Fusões, Aquisições de Empresas

GameStop Is Offering to Buy eBay for $56 Billion, CEO Ryan Cohen Says -- WSJ

3 de mai. de 2026, 22:57 UTC

Aquisições, Fusões, Aquisições de Empresas

GameStop Is Offering to Buy eBay For $56 Billion, CEO Ryan Cohen Says -- WSJ

3 de mai. de 2026, 22:57 UTC

Aquisições, Fusões, Aquisições de Empresas

GameStop Has Roughly 5% Stake in eBay, Cohen Says -- WSJ

3 de mai. de 2026, 22:57 UTC

Aquisições, Fusões, Aquisições de Empresas

GameStop Offering to Buy eBay for $125 a Share, or About $56 Billion, CEO Ryan Cohen Says -- WSJ

3 de mai. de 2026, 22:57 UTC

Aquisições, Fusões, Aquisições de Empresas

GameStop Is Prepared to Run Proxy Fight If eBay Isn't Receptive to a Deal, Cohen Says -- WSJ

3 de mai. de 2026, 22:57 UTC

Aquisições, Fusões, Aquisições de Empresas

GameStop Has Around $20 Billion in Debt Financing Committed From TD Bank, Cohen Says -- WSJ

3 de mai. de 2026, 22:45 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

3 de mai. de 2026, 22:45 UTC

Conversa de Mercado

Low-Cost Miners in Spotlight Amid High Energy Prices -- Market Talk

3 de mai. de 2026, 22:20 UTC

Ganhos

National Australia Bank Holds Dividend Despite 19% 1H Profit Drop

3 de mai. de 2026, 22:08 UTC

Ganhos

NAB's 1H Included Previously Announced A$1.35B Software Amortization Charge>NAB.AU

3 de mai. de 2026, 22:05 UTC

Ganhos

NAB 1H Net Interest Income A$9.16B Vs. A$8.445B>NAB.AU

3 de mai. de 2026, 22:05 UTC

Ganhos

NAB 1H Credit Impairment Charge A$706M Vs. A$348M>NAB.AU

3 de mai. de 2026, 22:05 UTC

Ganhos

NAB 1H Operating Expenses A$5.02B Vs. A$4.81B>NAB.AU

3 de mai. de 2026, 22:04 UTC

Ganhos

NAB 1H Net Interest Margin 1.81%>NAB.AU>NAB.AU

3 de mai. de 2026, 22:03 UTC

Ganhos

NAB 1H Cash Return on Equity Ex-Large Notable Items 11.6%>NAB.AU

3 de mai. de 2026, 22:03 UTC

Ganhos

NAB 1H Cash Return on Equity 8.5%>NAB.AU

3 de mai. de 2026, 22:02 UTC

Ganhos

NAB 1H CET1 Capital Ratio 11.65% Vs. 12.01%>NAB.AU

3 de mai. de 2026, 22:02 UTC

Ganhos

NAB 1H Cash Earnings A$2.64B>NAB.AU

3 de mai. de 2026, 22:02 UTC

Ganhos

NAB 1H Cash Earnings Ex-Notable Items A$3.59B Vs. A$3.58B>NAB.AU

3 de mai. de 2026, 22:01 UTC

Ganhos

National Australia Bank Keeps Dividend at A$0.85 >NAB.AU

3 de mai. de 2026, 22:01 UTC

Ganhos

National Australia Bank 1H Rev A$11.16B Vs. A$10.28B >NAB.AU

3 de mai. de 2026, 22:01 UTC

Ganhos

National Australia Bank 1H Net A$2.75B Vs. Net A$3.41B >NAB.AU

3 de mai. de 2026, 15:06 UTC

Ganhos

Berkshire's Greg Abel Marks His First Annual Meeting as CEO. We'd Give Him a B-Plus. -- Barrons.com

Comparação entre Pares

Variação de preço

Coloplast A-S (Class B) Previsão

Preço-alvo

By TipRanks

11.86% parte superior

Previsão para 12 meses

Média 901.38 DKK  11.86%

Máximo 1,056 DKK

Mínimo 720 DKK

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Coloplast A-S (Class B) - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

8 ratings

2

Comprar

4

Manter

2

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat